DGFT Notifies New SIONs for Azithromycin | Aldehyde C10 | Ceftazidime

Public Notice No. 14/2025-26, Dated 08-07-2025

The Director General of Foreign Trade (DGFT) has issued a Public Notice introducing three new Standard Input Output Norms (SIONs) under the Chemical & Allied Products group. These norms define the quantity of input materials permitted for manufacturing a specified quantity of export product under the Advance Authorisation scheme.

1. Newly Introduced SIONs

The details of the newly notified SIONs are as follows:

• SION A-3687 – Azithromycin Dihydrate

1. 1. Permitted Input – 0.9434 kg of Azithromycin Amine Dihydrate
   2. Per Output Unit – For every 1 kg of Azithromycin Dihydrate exported

• SION A-3688 – Aldehyde C10 (Capric Aldehyde)

1. 1. Permitted Input – 1.40 kg of Fatty Alcohol C10 (98% purity)
   2. Per Output Unit – For every 1 kg of Capric Aldehyde exported

• SION A-3689 – Ceftazidime Sterile Powder

1. 1. Permitted Input – 1280 mg of Ceftazidime for Injection (bulk sterile formulation for IM/IV use)
   2. Per Output Unit – For each 1 number of Ceftazidime Sterile Powder exported

2. Implication for Exporters Under Advance Authorisation Scheme

Exporters intending to avail duty-free import benefits under the Advance Authorisation scheme must now strictly comply with these newly notified input-output norms. These SIONs ensure standardisation and transparency in input consumption ratios and serve as a reference for both exporters and customs authorities.

3. Compliance and Operational Readiness

• Exporters dealing in the above-mentioned products should immediately align their Bill of Materials (BoM) and production documentation with the updated SIONs.
• Applications for advance authorisations must reflect these new norms to avoid discrepancies during clearance or post-export verification.